EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Hongbo Fu, Jinrong Li, Xunhua Xu, Caihuai Xia, Yajuan Pan iD

Computational and Mathematical Methods in Medicine · 20.09.2022 · 2022 · 1-10

DOI: 10.1155/2022/6234858 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Computational and Mathematical Methods in Medicine, erschienen am 20.09.2022. Verfasst von Hongbo Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Haikou Maternal and Child Health Hospital, Haikou 570203, China. Hauptthemen laut MEDLINE: Gastroenteritis, Probiotics, Saccharomyces boulardii. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Haikou Maternal and Child Health Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the efficacy and safety of Saccharomyces boulardii for the treatment of acute gastroenteritis in children aged under 5.

Methods

Two independent researchers retrieved literature from PubMed, OVID, Embase, ScienceDirect, and other databases, followed by extracting indicators of the primary endpoints. Cochrane Q test and I 2 statistics were used to evaluate interstudy heterogeneity. The relative risk (RR) and mean difference (MD) of related indicators were calculated and combined using the random- or fixed-effect model, as appropriate. Furthermore, the funnel plot and Egger’s test were used to evaluate the publication bias. A two-sided P < 0.05 denoted statistical significance.

Results

10 articles were included in this meta-analysis, with a total of 1282 children having acute gastroenteritis. The use of Saccharomyces boulardii in children with acute gastroenteritis could effectively shorten diarrhea duration ( MD = 19.70 , 95% CI: -24.87, 14.52) and reduce the length of hospital stay ( MD = − 0.91 , 95% CI: -1.28, -0.54). Compared with the control group, the RR of continued diarrhea was significantly lower in the treatment group after 1 day treatment ( RR = − 0.31 , 95% CI: 0.59, 0.03) and 3 days treatment ( RR = 0.52 , 95% CI: 0.41, 0.66). In addition, treatment with Saccharomyces boulardii reduced the average number of diarrhea after 3 days of treatment by about 1.03 ( MD = − 1.03 , 95% CI: -1.53, -0.53). There were no adverse drug reactions in both groups.

Conclusion

The use of probiotic Saccharomyces boulardii can significantly improve the symptoms of diarrhea in children with acute gastroenteritis and reduce the duration of diarrhea symptoms and the time of hospitalization. Meanwhile, the RR of continued diarrhea in children after 1 and 3 days of Saccharomyces boulardii treatment and the frequency of diarrhea after 3 days of Saccharomyces boulardii treatment were decreased. It is also safe and does not increase the incidence of adverse drug reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastroenteritisProbioticsSaccharomyces boulardiiChildDiarrheaHumansRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Emergency, Haikou Maternal and Child Health Hospital, Haikou 570203, China.
  • Department of Pediatrics, Haikou Hospital of Traditional Chinese Medicine, Haikou 570216, China.
  • Department of Pediatrics, Wenchang City People's Hospital, Wenchang 571300, China.

ORCID-Profile: Yajuan Pan

Förderung

  • Haikou Maternal and Child Health Hospital

Zitieren

APA

Fu, H., Li, J., Xu, X., Xia, C., & Pan, Y. (2022). Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Computational and Mathematical Methods in Medicine, 2022, 1-10. https://doi.org/10.1155/2022/6234858

Vancouver

Fu H, Li J, Xu X, Xia C, Pan Y. Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Computational and Mathematical Methods in Medicine. 2022;2022:1-10. doi:10.1155/2022/6234858

BibTeX
@article{Fu2022,
  author = {Fu, Hongbo and Li, Jinrong and Xu, Xunhua and Xia, Caihuai and Pan, Yajuan},
  title = {Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Computational and Mathematical Methods in Medicine},
  year = {2022},
  volume = {2022},
  pages = {1--10},
  doi = {10.1155/2022/6234858}
}
Kostenlos starten →